Business Type Exporter, Supplier
Form Powder
Rasburicase is also Approved to Prevent: Tumor Lysis Syndrome
Usage Used to Treat High Levels of Uric Acid in the Blood
Click to view more

Preferred Buyer From

Location Worldwide

Product Details

Dosage
As per Doctor's Prescription
Storage
Cool and Dry Place
Best Before
36 Months from Manufacturing

A drug used to treat high levels of uric acid in the blood of adults and children with leukemia, lymphoma, or other types of cancer who are receiving certain types of anticancer therapy. Uric acid is a natural substance that can build up in the blood as tumors break down. Rasburicase helps break down and remove uric acid from the body. It is a type of recombinant enzyme and a type of urate-lowering drug. Also called Elitek and recombinant urate oxidase.

 

Rasburicase is approved for use by the U.S. Food and Drug Administration (and European counterparts) for the prevention and treatment of tumor lysis syndrome (TLS) in people receiving chemotherapy for hematologic cancers such as leukemias and lymphomas. However, it is not clear if it results in important benefits such as decreased kidney problems or decreased risk of death as of 2017.

 

Rasburicase is approved to treat adults and children with:

 

High levels of uric acid in the blood.

Yes! I am interested

Looking for "Rasburicase Powder" ?

Kilogram

Explore More Products


Close

Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us